TTR and heart failure: Several studies have demonstrated that transthyretin has significant predictive value for morbidity and mortality in some patients, including those undergoing surgery for colorectal cancer [9], cardiac surgery [10], radical gastrectomy [11], stroke [12], systemic sclerosis outpatients [13], heart failure [14]and others.